0001104659-24-027574.txt : 20240226
0001104659-24-027574.hdr.sgml : 20240226
20240226170119
ACCESSION NUMBER: 0001104659-24-027574
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hudson Frederick M.
CENTRAL INDEX KEY: 0001438462
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 24679964
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm247055-11_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-22
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001438462
Hudson Frederick M.
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
1
0
0
0
0
Common Stock
33231
D
Director Stock Option (Right to Buy)
27.94
2024-02-22
4
A
0
8252
0
A
2034-02-22
Common Stock
8252
8252
D
Restricted Stock Units
2024-02-22
4
A
0
5369
0
A
Common Stock
5369
5369
D
The option vests on February 22, 2025.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025.
/s/ Timothy C. Dec, as attorney-in-fact
2024-02-26